A new trading day began on May 19, 2023, with Pfizer Inc. (NYSE: PFE) stock priced at $36.65, up 0.79% from the previous day of trading. During the day, the shares moved up to $37.654 and dropped to $36.52 before settling in for the closing price of $36.48. PFE’s price has ranged from $36.17 to $54.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 13.80% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 39.30%. With a float of $5.61 billion, this company’s outstanding shares have now reached $5.63 billion.
In an organization with 83000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +61.89, operating margin of +37.43, and the pretax margin is +34.61.
Pfizer Inc. (PFE) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc. is 0.04%, while institutional ownership is 70.50%. The most recent insider transaction that took place on May 08, was worth 38,580. In this transaction Director of this company bought 1,000 shares at a rate of $38.58, taking the stock ownership to the 6,000 shares. Before that another transaction happened on May 05, when Company’s Director bought 1,000 for $38.42, making the entire transaction worth $38,425. This insider now owns 5,000 shares in total.
Pfizer Inc. (PFE) Performance Highlights and Predictions
In its latest quarterly report, released on 3/30/2023, the company reported earnings of $1.23 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of +31.26 while generating a return on equity of 36.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -14.94% during the next five years compared to 22.70% growth over the previous five years of trading.
Pfizer Inc. (NYSE: PFE) Trading Performance Indicators
Here are Pfizer Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.22. Likewise, its price to free cash flow for the trailing twelve months is 18.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.07, a number that is poised to hit 0.61 in the next quarter and is forecasted to reach 3.55 in one year’s time.
Technical Analysis of Pfizer Inc. (PFE)
Let’s dig in a bit further. During the last 5-days, its volume was 25.23 million. That was better than the volume of 22.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 15.48%. Additionally, its Average True Range was 0.64.
During the past 100 days, Pfizer Inc.’s (PFE) raw stochastic average was set at 3.81%, which indicates a significant decrease from 15.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 11.02% in the past 14 days, which was lower than the 18.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.64, while its 200-day Moving Average is $44.80. However, in the short run, Pfizer Inc.’s stock first resistance to watch stands at $37.44. Second resistance stands at $38.12. The third major resistance level sits at $38.58. If the price goes on to break the first support level at $36.31, it is likely to go to the next support level at $35.85. Assuming the price breaks the second support level, the third support level stands at $35.17.
Pfizer Inc. (NYSE: PFE) Key Stats
With a market capitalization of 205.94 billion, the company has a total of 5,645,307K Shares Outstanding. Currently, annual sales are 100,330 M while annual income is 31,372 M. The company’s previous quarter sales were 18,282 M while its latest quarter income was 5,543 M.
